Skip to main content
. 2022 Nov 5;11(21):3507. doi: 10.3390/cells11213507
OS Osteosarcoma
MSTS Musculoskeletal tumors
AJCC American Joint Committee on Cancer
EFS Event-free survival
NK Natural killer cell
NKT Natural killer T cell
COG Children’s Oncology Group
PI3K Phosphoinositide-3 kinase
PIK3CA Phosphatidylinositol 3-kinase
mTOR Mechanistic target of rapamycin
IGF Insulin-like growth factor
IGF-1R Insulin-like growth factor 1 receptor
VEGF Vascular endothelial growth factor
VEGFA Vascular endothelial growth factor A
KDR Kinase insert domain receptor
PDGF Platelet-derived growth factor
PDGFR Platelet-derived growth factor receptor
DDR DNA damage response
KIT KIT proto-oncogene receptor tyrosine kinase
MYC Avian myelocytomatosis viral oncogene homolog
CDK Cyclin-dependent kinase
CCNE1 Cyclin E1
CCND2 Recombinant human cyclin-D2
PTEN Phosphatase and tensin homolog deleted on chromosome ten
ADP Adenosine diphosphate
PARP Poly ADP-ribose polymerase
TP53 Tumor protein p53
RB1 Retinoblastoma1
PDX Patient-derived xenograft
PDOX Patient-derived orthotopic xenograft
ADR Adriamycin
SCID Server combined immune-deficiency
MEK Mitogen-activated protein kinase kinase
MAPK Mitogen-activated protein kinase
GPNMB Glycoprotein non-metastatic melanoma protein B
CAR-T Chimeric antigen receptor T
HER2 Human epidermal growth factor receptor-2
BsAb Bispecific antibody